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Background
ASSIT is a novel therapy of allergic diseases that gained
significant acceptance over the past decade. This study
was undertaken to investigate whether ASSIT in PAR may
influence the Intracellular expression of IFN- gamma and
IL-4 by CD3+CD8+ T-cells.
Subjects and methods
Twenty adult PAR patients sensitive only to the mite D.
farinae as diagnosed by Prick skin testing (PST) [Omega
labs, Montreal, Canada] were included in the study. ASSIT
to D. farinae was administered for 6 months.
Flow cytometric evaluation of the intracellular expres-
sion of IL-4 and IFN- gamma by CD3+ CD8+ T-cells was
determined according to Manufacturer instructions (Beck-
ton Dickenson) before and after ASSIT.
The total 5 symptom score (T5SS) of PAR and the
diameter of PST were also examined.
Results
After ASSIT; the percentage of Il-4 expressing CD8+
T-cells significantly decreased from [0.69 +/- 0.18] to
[0.33 +/- 0.13] and the percentage of IFN-gamma
expressing CD8+ T-cells significantly increased from
[4.63 +/- 1.29] to [7.20 +/- 2.09]. The T5SS and the
PST diameter also significantly decreased.
Conclusion
In this study the favorable clinical response induced by
ASSIT in PAR correlated with the decrease in the
percentage of Tc2 cells and the increase in the percen-
tage of Tc1 cells.
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